Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Eton Pharmaceuticals, Inc.

NASDAQ: ETON · Life Sciences · 10 alerts · CIK 1710340

Eton Pharmaceuticals, Inc. stories on ALFA USA NewsRead the news →
Share price
$63.88Close, Nov 16
Market cap
$1.84B
Shares outstanding
28.84MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Eton Pharmaceuticals, Inc. filings on SEC EDGAR ↗

7:00 AM ET 8-K
Research Collaboration

Eton Pharmaceuticals Research Collaboration with Baylor College of Medicine

Eton Pharmaceuticals has entered into a license and development agreement with Baylor College of Medicine to evaluate mecasermin (ET-900) for the treatment of infantile and epileptic spasms. The partnership includes an investigator-sponsored Phase 2 clinical study with patient dosing targeted for Q1 2027, following the submission of an Investigational New Drug application to the FDA.

Counterparty
Baylor College of Medicine

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.